购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-11 (Compound 2) 是一种抑制羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的化合物,其IC50值对于白三烯 B3 和雌二醇分别为 ≤ 1 μM和 ≤ 0.1 μM。该化合物主要用于研究肝病、代谢性疾病或心血管疾病,例如非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪性肝炎 (NASH) 或药物性肝损伤 (DILI)。
HSD17B13-IN-11 (Compound 2) 是一种抑制羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的化合物,其IC50值对于白三烯 B3 和雌二醇分别为 ≤ 1 μM和 ≤ 0.1 μM。该化合物主要用于研究肝病、代谢性疾病或心血管疾病,例如非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪性肝炎 (NASH) 或药物性肝损伤 (DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-11 (Compound 2), with IC50 values of ≤ 1 μM for leukotriene B3 and ≤ 0.1 μM for estradiol, effectively inhibits hydroxysteroid 17β-dehydrogenase 13 (HSD17B13). This compound is utilized in studying various medical conditions including liver diseases, metabolic and cardiovascular disorders, particularly non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI) [1]. |
分子量 | 352.84 |
分子式 | C16H17ClN2O3S |
CAS No. | 2758802-03-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容